SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-026915
Filing Date
2022-05-16
Accepted
2022-05-16 13:25:24
Documents
71
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_bioessence.htm   iXBRL 10-Q 453801
2 CERTIFICATION f10q0322ex31-1_bioessence.htm EX-31.1 11270
3 CERTIFICATION f10q0322ex31-2_bioessence.htm EX-31.2 10385
4 CERTIFICATION f10q0322ex32-1_bioessence.htm EX-32.1 5952
5 CERTIFICATION f10q0322ex32-2_bioessence.htm EX-32.2 5900
6 GRAPHIC image_001.jpg GRAPHIC 20103
  Complete submission text file 0001213900-22-026915.txt   3556735

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cik00001723059-20220331.xsd EX-101.SCH 53415
8 XBRL CALCULATION FILE cik00001723059-20220331_cal.xml EX-101.CAL 34524
9 XBRL DEFINITION FILE cik00001723059-20220331_def.xml EX-101.DEF 190546
10 XBRL LABEL FILE cik00001723059-20220331_lab.xml EX-101.LAB 375646
11 XBRL PRESENTATION FILE cik00001723059-20220331_pre.xml EX-101.PRE 197069
65 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_bioessence_htm.xml XML 334017
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 22927395
SIC: 2834 Pharmaceutical Preparations